Evolus, Inc. (EOLS)
4.69
+0.16
(+3.53%)
USD |
NASDAQ |
Apr 17, 16:00
4.67
-0.02
(-0.43%)
After-Hours: 20:00
Evolus Research and Development Expense (Quarterly) : 3.481M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 6.452M |
| STAAR Surgical Co. | 9.042M |
| Sanara MedTech, Inc. | 2.036M |
| Quantum-Si, Inc. | 10.95M |
| Plus Therapeutics, Inc. | 2.941M |